Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Cepheid COVID-19 test price reduction protest Photograph by Sophia Apostolia
Press release
Press release |
06 September 2021
COVID-19

MSF demands Cepheid justify inadequate price reduction of COVID-19 tests

3 min
MSF Counsellor, counselling parents of a six-year-old girl with drug-resistant TB at MSF independent Clinic, Mumbai- India Photograph by Atul Loke
Press release
Press release |
03 September 2021
Tuberculosis

Lifesaving TB medicines must be affordable and available to make all-oral treatments for children a reality

4 min
A member of MSF’s mobile vaccination team prepares a dose of COVID-19 vaccine.
Press release
Press release |
23 August 2021
COVID-19
United States of America

Following full FDA approval, Pfizer and BioNTech must urgently share COVID-19 vaccine know-how to increase global production and supply

Sebastião da Silva, 43 years old, is unemployed and went out of his house to get food for his 3 kids and wife. He is a painter and is having a hard time getting a job.If I get the virus, I wouldn’t know what to do.” Photograph by Mariana Abdalla
Press release
Press release |
26 July 2021
COVID-19

Opposing countries must stop filibustering negotiations on ‘TRIPS Waiver’ at WTO 

6 min
A health worker with Puerto Rico Salud vaccinates a resident of Humacao on the eastern coast of Puerto Rico, at a public vaccination event. Photograph by Gabriella N. Báez
Press release
Press release |
22 July 2021
COVID-19

MSF: No COVID-19 booster shots anywhere before healthcare workers and vulnerable people everywhere have access

4 min
Treating COVID-19 second wave in South Africa Photograph by Chris Allan
Press release
Press release |
21 July 2021
COVID-19
South Africa

COVID-19 vaccines: Pfizer-BioNTech and Biovac “fill and finish” deal is step in right direction but much more needed to support vaccine independence in Africa

3 min
MSF treats patients with a liposomal Amphotericin B, sold by Gilead under the brand name AmBisome. Photograph by Misha Friedman
Press release
Press release |
21 July 2021
HIV/AIDS

Breakthrough in treatment of HIV-related cryptococcal meningitis gives Gilead another opportunity to fulfil its promise to scale up access to lifesaving drug

5 min
Banner deployed by MSF in front of the World Trade Organization (WTO) in Geneva calling on certain governments to stop blocking the landmark waiver proposal on intellectual property (IP) during the pandemic.
Press release
Press release |
14 July 2021
COVID-19

As Chancellor Merkel visits US, MSF urges Germany to stop blockade on pandemic ‘TRIPS waiver’

  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury